Murphy & Mullick Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Sell
3,753
-423
-10% -$38.6K 0.21% 98
2026
Q1
$429K Sell
4,176
-698
-14% -$78.8K 0.32% 73
2025
Q4
$611K Sell
4,874
-109
-2% -$13.9K 0.44% 54
2025
Q3
$667K Sell
4,983
-155
-3% -$20.3K 0.5% 52
2025
Q2
$648K Hold
5,138
0.53% 48
2025
Q1
$682K Sell
5,138
-167
-3% -$21.3K 0.66% 41
2024
Q4
$600K Buy
+5,305
New +$613K 0.55% 43

Other funds holding ABT

Murphy & Mullick Capital Management's ABT Position: Q2 2026 in Review

Murphy & Mullick Capital Management reduced its Abbott (ABT) stake by 10% in Q2 2026, selling an estimated $38.6K and leaving 3,753 shares worth $341K. The position accounts for 0.21% of the portfolio, ranked #98.

Murphy & Mullick Capital Management first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $682K in Q1 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Murphy & Mullick Capital Management held 3,753 shares of Abbott worth $341K as of Q2 2026.
  • Murphy & Mullick Capital Management sold 423 Abbott shares in Q2 2026, an estimated $38.6K.
  • Abbott made up 0.21% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #98 holding.
  • Murphy & Mullick Capital Management first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Murphy & Mullick Capital Management's Abbott position peaked at $682K in Q1 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.